The aim of the present study is to describe the prevalence of sleep disorders in a large group of patients with Chiari malformation type 1 (CM-1) and determine the presence of risk factors associated with these abnormalities. Methods: Prospective study with consecutive patient selection. We included 90 adult patients with CM-1, defined by the presence of a cerebellar tonsillar descent (TD) ≥3 mm. Clinical, neuroradiological studies, and nocturnal polysomnography (PSG) was carried out. In addition, patients were also subclassified into 2 CM subtypes: CM-1, with the obex above the foramen magnum (FM) and CM-1.5, in which along with a TD ≥3 mm, the obex was located below the FM. Results: We observed a high prevalence (50%) of sleep-related breathing disorders (SRBDs) with predominant hypopnea. Only six patients showed a central apnea index of ≥5. Hypoventilation was observed in only three patients. SRBD severity was associated with male sex, older age, excess weight, and the presence of hydrocephalus. No differences in clinical or PSG parameters were found when comparing CM subtypes (CM-1 and CM-1.5). Sleep architecture study showed decreased sleep efficiency with an increase in arousal and waking after sleep onset. The presence of SRBDs was found to be associated with poorer sleep architecture parameters. Conclusions: This study confirms a high prevalence of SRBDs in patients with CM-1 and CM-1.5, with a predominant obstructive component. Nocturnal PSG recordings should be systematically conducted in these patients, especially those who are male, older, or overweight or those who present hydrocephalus.
INTRODUCTION
Chiari malformation type 1 (CM-1) is a congenital hindbrain anomaly characterized by a cerebellar tonsillar descent (TD) below the plane of the foramen magnum (FM) of at least 3 mm. 1 The presence of a small volumetric posterior cranial fossa is the most common finding in these patients, and consequently, compression of the cerebellum, the lower brain stem, and/or the upper cervical spinal cord may occur. [2] [3] [4] Due to mechanical obstruction of cerebrospinal fluid (CSF) circulation at the level of the craniovertebral junction (CVJ), patients with CM-1 may concomitantly present syringomyelia and/or hydrocephalus. [5] [6] [7] Less frequently, bone abnormalities of the CVJ may also be present. 8, 9 Recently, Tubbs et al. introduced the term CM type 1.5 (CM-1.5) to describe a subgroup of patients classically included in the CM-1 definition who, in addition to tonsillar herniation, had an elongated brain stem, resulting in an obex location below the level of the FM. 10 The compressive effect on neural structures at the level of the FM may also produce alterations in the lower cranial nerves, sleep-regulating structures, and cardiorespiratory centers. [11] [12] [13] [14] These different alterations make the clinical presentation of CM-1 very heterogeneous. Headaches, neck pain, paresthesia, dizziness, unsteady gait, motor deficits in the upper or lower limbs, dysphagia, and nocturnal respiratory disorders are frequent symptoms reported by these patients. 6, 9, 11, 13 Dysfunction in the respiratory centers has been described in patients with CM-1 and implicated in sleep-related breathing disorders (SRBDs). In these patients, SRBDs may be an etiological factor in potentially fatal complications, including respiratory failure, [15] [16] [17] [18] [19] postoperative susceptibility to respiratory failure, [20] [21] [22] [23] and even sudden death. 18, [24] [25] [26] [27] [28] [29] [30] SRBDs, which include nocturnal hypoventilation and central or obstructive sleep apnea, represent a chronic condition associated with disruption of sleep continuity and intermittent hypoxemia, leading to serious adverse effects. 31, 32 SRBDs may cause daytime hypersomnolence and is a risk factor for increased incidence of cardiovascular disease, 32, 33 impaired quality of life, 34 motor accidents, 35 and increased mortality. 36, 37 Duran et al. estimated that 28% of women and 26% of men in Spain have obstructive sleep apnea syndrome based on the criterion of an apnea-hypopnea index (AHI) score of 5 or higher. 38 The prevalence of SRBDs reported in the literature in adult patients with CM-1 is significantly higher (60%-75%). 11, 12, [39] [40] [41] However, these studies presented significant heterogeneity and included case reports 16, 24, [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] or small cohorts of patients with different subtypes of the CM (types 1 and 2), different age ranges, and different concomitant structural abnormalities, making the interpretation of the results difficult. 11, 39, 41, 56, 57 In addition, data on the prevalence and significance of both obstructive apnea and central apnea in patients with CM-1 is still lacking, and the clinical and neuroradiological predictive factors for SRBDs in patients with CM- 1 have not yet been identified.
In the present study, we describe the frequency and severity of SRBDs and sleep architecture alterations in a cohort of 90 adult patients who had been diagnosed with classical CM-1. The goal of the study was to verify or refute the hypothesis that respiratory and sleep abnormalities are frequent in patients with CM-1 and that these alterations are more serious in the CM-1.5 subgroup.
PATIENTS AND METHODS

Patient Selection
Patients included in this study were prospectively selected from a group of patients diagnosed with primary CM-1 who had been referred to the Department of neurosurgery at Vall d'Hebron University Hospital (VHUH) between 2006 and 2013 ( Figure 1 ). Inclusion criteria consisted of adult age (≥18 years), no previous posterior fossa surgery, and a diagnosis of CM-1 based on the Barkovich criterion (TD ≥3 mm below the FM identified by midsagittal T1-weighted magnetic resonance imaging [MRI]). 1 The study protocol for these patients has been previously published 58 and included clinical evaluation, neurological examination, cranial and spinal MRI, computed tomography (CT) of the CVJ with coronal, sagittal, and 3D reconstructions, and neurophysiological examination (brain stem auditory-evoked potentials, somatosensory-evoked potentials, and nocturnal polysomnography [PSG] ). 58 Anamnesis included clinical manifestations and a systematic interview about sleep complaints, which focused mainly on excessive daytime sleepiness. Sleepiness was evaluated using the Epworth sleepiness scale (ESS) and was considered abnormal when the ESS score was >11. 59 Patients were excluded if they presented complex CVJ malformation, defined as the coexistence of tonsillar herniation, and at least three of the following abnormalities: significant retroflexed odontoid, basilar invagination (BI), platybasia, severe bone abnormalities in the C0-C2 complex, unilateral or bilateral occipital condyle hypoplasia, atlanto-occipital assimilation, and other abnormalities that cause anterior compression of the cervicomedullary junction. 58 Additional exclusion criteria were adenoidal or tonsillar hypertrophy, advanced congestive failure, and the use of psychotropic medication or other medications that affect sleep and/or SRBDs. Patients who underwent cardiorespiratory polygraphy (CRP) recordings instead of the conventional PSGs were also excluded. CRP instead of PSG was performed in some patients because access to conventional nocturnal PSG for patients referred to the VHUH was limited. In comparing these 30 patients with the 90 PSG-studied patients, we did not find any significant differences in terms of the CM subtype, body mass index (BMI), age, or ESS score. The present study was approved by the ethics committee of the VHUH (protocol #:PR-AG-326/2013), and written informed consent was obtained from all patients.
Chiari Malformation Type 1 Subclassification
The neuroradiological criteria generally used to define CM-1, which remain arbitrary and widely variable, are based on the finding of at least one of the cerebellar tonsils extending below the planum of the FM (basion-opisthion line). These variable cutoffs were obtained from several studies analyzing the relative position of the cerebellar tonsils in healthy volunteers, cohorts of patients with MRI imaging, and patients with symptomatic CM. Barkovich et al. were greatly active in defining CM-1 as a tonsillar herniation ≥3 mm below the FM. 1 However, the wide availability of high-field MRIs has allowed many patients with CM-1 to be studied in detail, showing that traditional neuroradiological criteria are not sensitive or specific enough for CM diagnosis nor do they correlate well with the more severe symptoms present in some patients, such as syringomyelic syndrome or sleep apnea. 60 With the aim of correlating neuroradiological and clinical findings, we subclassified our cohort of patients according to the criteria used in the recent literature. 10, 58, [61] [62] [63] Initially, all patients were considered to present "classical CM-1," but for the purpose of this study, they were reclassified into two subgroups: CM type 1, with a TD measuring ≥3 mm below the FM and the obex located above the level of the FM, and CM type 1.5, with a TD ≥3 mm and the obex located below the FM level ( Figure 1 ). In this classification, we introduced a minor modification, previously described elsewhere, 58 in the threshold used to differentiate CM-1 from CM-1.5. We used a cutoff of 3 mm rather than the 5-mm value proposed by Tubbs et al., since it has been shown that the degree of TD is not related to the severity of symptoms or the presence or absence of syringomyelia. 4, 6, 11 Neuroimaging Studies In addition to detecting TD below the FM, the presence or absence of hydrocephalus, BI, retroflexion of the odontoid process, and syringomyelia were also evaluated. Hydrocephalus was defined by an Evans index (EI) of ≥0.30, which was calculated by dividing the maximum bifrontal distance in the axial MRI slice by the maximum inner diameter of the skull at the same level of measurement. 64 BI was defined as a congenital abnormality in which the tip of the odontoid process projected above the Chamberlain line by at least 6 mm. 
. Video and audio-recordings were obtained for each study.
Respiratory Scoring Criteria
Apnea was defined as complete or near-complete cessation of airflow for >10 seconds (drop in the peak signal excursion by ≥90% of preevent baseline using an oronasal thermal sensor). Differentiation was made between obstructive and central apneas according to respiratory effort channels (the presence or absence of thoracoabdominal movement). Hypopnea was defined as a ≥30% reduction in flow amplitude with respect to the baseline using a nasal cannula pressure sensor with duration of at least 10 seconds and associated with either a drop of at least 3% in oxygen saturation (SatO 2 ) or arousal. Respiratory effort-related arousal (RERA) was defined as a sequence of breaths lasting 10 seconds and characterized by increasing respiratory effort or flattening of nasal pressure waveforms, leading to an arousal when the sequence of breaths did not meet the criteria for apnea or hypopnea. The AHI was defined as the sum of apnea and hypopnea divided by total sleep time (TST). The respiratory disturbance index (RDI) was defined as the sum of the number of apneas plus hypopneas and RERAs divided by TST. The diagnosis of SRBDs, established according to the definitions of the AASM, 66 required an RDI ≥5, with a stratification of mild (RDI: 5-14.9), moderate (RDI: 15-29.9), or severe (RDI: ≥30). We also calculated the oxygen desaturation index as a reduction in SaO 2 of ≥3%, and hypoventilation, which was defined when the cumulative percentages of time spent with SaO 2 at <90% (CT90) were ≥30% of the TST.
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Sleep Architecture
Sleep architecture was assessed using standard techniques defined by the AASM. 65 The sleep parameters evaluated were (1) TST, defined as time spent in sleep stages N1, N2, N3, and rapid eye movements (REM); (2) 
Statistical Analysis
Descriptive statistics were obtained for each variable. For continuous variables, summary statistics included the mean, median, range, and the SD. Percentages and sample sizes were used to summarize categorical variables. The Shapiro-Wilk test and inverse probability plot were used to determine whether data followed a normal distribution. To compare the different variables of the study and evaluate the possible association between them, the appropriate test was applied according to the compliance of the application criteria. Statistical analyses were carried out with R v3.2.3 (R Foundation for Statistical Computing, Vienna, Austria; http://www.R-project.org) and the integrated development environment R Studio v0.99.879 (RStudio, Inc., Boston, MA, USA; http://www.rstudio.com). Values of p < .05 were considered statistically significant.
RESULTS
Patient Group
Of the 336 patients with CM-1 admitted to the Department of Neurosurgery at the VHUH during the study period, 127 were excluded because of age (<18 years). Forty patients were excluded because they were referred to our center for a second opinion with previous studies and/or surgery performed at other centers, which could have involved different methodologies. Thirty patients were excluded because they underwent cardiopulmonary resuscitation study instead of conventional PSG. Seven patients had a complex CVJ malformation. Additional exclusion criteria were found in 42 patients. The final series included 90 patients who met all inclusion criteria and none of the exclusion criteria (Figure 2 ).
Demographic and Clinical Data
The demographic and clinical data of the patient group are summarized in Table 1 . Briefly, 64.4% of the participants were women and 35.5% were men, with a mean age of 42 ± 12.2 years. The median TD of the complete group (n = 90) was 9 mm (minimum [min]: 3, maximum [max]: 30). Nine (10%) patients-8 in the CM-1 group and 1 in the CM-1.5 group-had a tonsillar descent <5 mm. The BMI of the complete study group was 25.6 ± 4.1, and the median ESS score was 5.0 (min: 0, max: 16), with an ESS score that was ≥11 in 7% of patients (Table 1) . Eighty-four patients were clinically symptomatic and/or showed abnormal neurological findings on examination. The most common symptoms in this cohort were headache (80.0%), followed by sensory abnormalities (55.6%), and dizziness (40.0%). Abnormal cranial motor nerve manifestations (VII, IX, X, XI, and XII) were present in 22.2% of patients. The most frequent associated problems were syringomyelia (47.8%), hydrocephalus (18.9%), and retroflexed odontoid (18.9%), followed by BI (12.2%).
The CM-1 subtype was found in 77.7% of patients (n = 70), while the remaining 22.3% (n = 20) were classified as CM-1. (Table 1) .
Respiratory Sleep Parameters
Forty-five (50%) of the 90 patients studied were found to have SRBDs (RDI ≥5), which was moderate or severe in 27.8% of the total cohort ( Table 2 ). The median RDI in these patients was 5.1 (min: 0.75, max: 57). We scored few RERAs with minimal differences in the overall comparison between RDI and AHI, and no differences in SRBD prevalence for both parameters with a cutoff of 5.1 e/h. The low RERA events could be explained by the new hypopnea definition, which includes a 30% cutoff for decrease in flow amplitude instead of 50%. The predominant respiratory abnormalities were hypopneas, which were more frequently present in the supine position and during REM sleep (Table 2 ). In patients with apnea, the obstructive sleep subtype was predominant. Only 6 (6.6%) patients presented a CAI ≥5. Five patients presented both central and obstructive respiratory events, but only one presented entirely central events. Central sleep apneas increased in prevalence with higher SRBD severity. Only three patients presented hypoventilation ( Table 2 ). The median SaO 2 of the complete series was 95% (min: 59, max: 96), without statistically significant differences between patients with CM-1 and patients with CM-1.5 (p = .342). Likewise, no statistically significant differences in SRBD frequency or respiratory parameters between CM-1 and CM1.5 subtypes were observed (Table 2) .
Associations Between SRBDs and Clinical and Anatomical Parameters
An increased frequency of moderate-to-severe SRBDs was found to be associated with male sex (p = .012), older age (p = .001), excess weight (p = .030), and the presence of hydrocephalus (p = .010; Table S1 ). SRBDs were present in 13 (76.5%) of the 17 patients with CM associated with hydrocephalus (in 9 SRBDs were moderate or severe) and was present in only 43.8% of patients without hydrocephalus. No differences in SRBD prevalence were found when comparing the CM-1 and CM-1.5 subgroups nor when evaluating the presence or absence of clinical manifestations or additional associated problems (syringomyelia, retroflexed odontoid, or BI; Table S1 ).
Sleep Architecture Findings
Sleep architecture parameters obtained are presented in Table  S2 . When we compared the sleep architecture of the different CM subtypes (CM-1 and CM-1.5), no statistically significant differences in sleep parameters were found (Table S2) . However, the results were different when we analyzed patients with and without SRBDs. Patients with SRBDs (RDI ≥5) showed poorer sleep quality with significantly increased N1 sleep stages and arousal when we compare to patients without SRBD (Table  S3) . Likewise, sleep architecture and sleep fragmentation were worse in patients with more severe SRBDs (RDI ≥15). These patients showed a greater decrease in SE and the amount of REM sleep, and a greater increase in N1 sleep stages, arousal, and periodic limb movement Index (PLMI).
PLM remained in the normal range in both CM subtypes but was significantly greater in patients with CM-1 (p = .035; Table  S2 ). PLM was found to be within the pathological range (PLM ≥15) in 26.6% of patients with SRBDs, with increased prevalence (44%) in moderate-to-severe SRBDs. Syringomyelia was not found to be associated with greater PLM prevalence (p = .702).
Respiratory and Sleep Abnormalities in Asymptomatic Patients
Six patients in our series were asymptomatic at the time of diagnosis but had undergone MRI for other reasons (e.g., trauma), resulting in incidental diagnosis. The median age of these six patients was 42.5 years (min: 18, max: 67), while the median BMI was 23.1 (min: 15, max: 29), and the median ESS score was 6.0 (min: 4, max: 10). All asymptomatic patients were included in the CM-1 subtype group. Of these six asymptomatic patients, in whom CM-1 was discovered incidentally, four patients presented SRBDs and in three cases SRBDs were severe. The median RDI in these patients was 18.9 (min: 0, max: 55). When comparing age, BMI, and ESS, no statistical differences between symptomatic and asymptomatic patient groups were found.
DISCUSSION
In our study, we found a high prevalence (50.0%) of SRBDs in adult patients with CM-1 diagnosed according to the classical criteria, and we did not find an increased frequency of SRBDs in patients with CM-1.5. Obstructive hypopneas were the predominant respiratory event observed, particularly when patients slept in supine position and during REM sleep. Excess weight was associated with SRBDs, while male sex and older age were associated with a greater severity of these disorders. Hydrocephalus was also found to be associated with the presence and severity of SRBDs.
Prevalence and Possible Causes of SRBDs in Patients With CM-1
Several studies conducted on adults with CM-1 have reported a higher prevalence of SRBDs (59%-75%). 12 However, only 5 of these studies included more than 10 CM-1 patients, and only 1 had 40 patients. 11, 39, 41, 56, 57 In the present study, we report on the largest cohort of adult patients with CM-1 to date. Notably, we observed a slightly lower prevalence and severity of SRBDs than described in previous studies. 11, 39, 41, 56, 57 However, 50% of our 90 patients presented SRBDs, which were moderate to severe in ~30%.
Obstructive hypopnea was the most predominant respiratory event found in our patients. We scored few RERAs with minimal differences values in the overall compute between RDI and AHI, without differences in prevalence of SRBD for both parameters for a cutoff of 5.1 e/h. This low RERAs compute probably could be explained by the inclusion in the new hypopnea definition, a 30% cutoff in flow amplitude instead of 50%.
We observed a lower prevalence of central events (6.7%) than that described in previous studies (15.4%-50%).
11,39,41,56,57 Only 6 of our 90 patients had a CAI score ≥5, and only one of these six presented pure central sleep apnea. In the literature, isolated case reports and small series have reported a high prevalence of central sleep apnea in patients with CM-1. 39, 56 However, in reports on greater numbers of patients, a predominance in obstructive respiratory events was also found, reflecting a possible bias in smaller cohorts. 11, 41 In addition, hypoventilation had a very low prevalence and severity in our patient group when compared with previous studies.
11 ,41 Some of these differences may be explained by differences in inclusion criteria and the intrinsic heterogeneity of patients with CM-1. 11, 39, 41 The degree of TD did not correlate with the presence of nocturnal respiratory disorders in our study.
SRBDs in patients with CM may be caused by several mechanisms 2, 3, 6, 68, 69 that involve direct compression of the central respiratory centers 70, 71 and/or compression of the lower cranial nerves (VII, VIII, IX, X, XI, and XII), 72 producing central and obstructive respiratory events, respectively. Hypothetically, obstructive respiratory events could be related to lesions in the efferent cranial nerves (IX, X, XI, and XII), possibly leading to pharyngeal collapse due to muscular hypotonia or atrophy. 72 Certain biotype factors present in some patients with CM-1 may also be associated with an increased risk of obstructive events and should be studied prospectively in future studies. 73 Retrognathia, increased neck circumference, and macroglossia have been associated with small oral cavity and may also be involved in the pathophysiology of SRBDs in patients with CM. 74 Central respiratory events could be related to dysfunction of the central respiratory centers due to compression of the brain stem, which compromises the ascending reticular activating system. 56 Another explanation for the central respiratory events in these patients could be the potential dysfunction of the afferent inputs from the carotid bodies to the brain stem. 14 
Risk Factors Associated With SRBDs
As in previous studies of both patients with CM 11, [39] [40] [41] 56, 57 and the general population, 38, 67 we observed that SRBDs were related with excess weight, male sex, and older age. Excess weight was found to be an independent factor for predicting the presence of moderate-to-severe SRBDs in our patients. These results highlight the importance of strict weight control in patients with CM. An additional risk factor for SRBDs in the present series was the presence of hydrocephalus. After completing an exhaustive clinical evaluation, we did not find any significant associations between clinical manifestations and SRBDs in our cohort. Furthermore, the asymptomatic patients in whom CM diagnosis was incidental presented an even higher SRBD prevalence when compared to the symptomatic patients described in this series. Although no definitive conclusions can be drawn due to the small group of incidental patients studied, it is important to note that sleep apnea syndrome may also be present in these patients and that SRBDs can be the first clinical manifestation of CM-1. 16, 24, [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] In the present series, hydrocephalus was associated with the presence and severity of SRBDs. The relationship between hydrocephalus and SRBDs in patients with CM may be explained by several mechanisms. It has been postulated that increased intracranial pressure (ICP), secondary to nocturnal hypercapnia and vasodilatation during apnea-hypopnea episodes, could be one such mechanism. 72 At the same time, hydrocephalus may impair certain brain hemisphere functions essential to the maintenance of upper airway patency during sleep. 75, 76 On the other hand, SRBDs may contribute to the development of hydrocephalus and syringomyelia in patients with CM, due to increased ICP associated with CSF disturbances at the level of the FM. 77 An increase in ventricular dilatation may lead to secondary neuronal dysfunction in infratentorial structures by increasing the herniation of the cerebellar tonsils. 75 With regard to the association between SRBDs together with CM and other concomitant pathologies, such as syringomyelia or BI, previous studies have presented contradictory results. Some authors suggested that the presence of syringomyelia 39, 78 and BI 11, 39 was associated with an increased risk of SRBDs. The same authors, however, later found a lower prevalence of SRBDs in patients with CM-1 having syringomyelia. 11 In the present study, no association between SRBDs and syringomyelia, BI, or retroflexed odontoid was found.
Additional Sleep Abnormalities
Few previous studies have evaluated additional sleep parameters in patient with CM-1 using complete nocturnal PSG. 11, 39, 41, 56 The most consistent findings in these studies were decreased TST and efficiency (74%-76%) 39, 41, 56 and an increased arousal index. 11, 56 Controversial results were described when reporting on slow-wave sleep and REM sleep. 39, 41 Our study shows low SE and an increased arousal index in the 90 patients studied but also found increased WASO and decreased REM sleep. This could be related to dysfunction of the reticular system and/or the sleep nucleus, 79 producing increased hyperarousal, an increased wake state, and sleep fragmentation during the sleep period. 80 Hypersomnia has been reported in both adult and pediatric patients with CM-1, all of whom were found to have severe SRBDs. 39, 41, 56 However, contrary to previous studies, and despite the poor sleep quality found in our patients, we observed a low prevalence of somnolence, regardless of the presence or absence of SRBDs. Similarly, a low prevalence of somnolence has been described in the general population and in patients with SRBD without CM. 67, 81 Regarding PLM, we found a lower prevalence of this symptom during sleep than previously described. 43, 82 The previously reported association between PLM and syringomyelia 43, 82 was not observed in our series.
The Role of PSG in Patients With CM-1 SRBD is an independent risk factor for cardiovascular disease, increased mortality, poorer quality of life, and increased motor accidents. 83 Treatment of SRBDs has been shown to be effective in terms of clinical and cardiovascular improvement. 83 Our results demonstrate high SRBD prevalence in CM-1, even in asymptomatic patients. Based on this finding, we recommend that PSG be systematically conducted on all patients with CM-1, especially in men with excess weight, older age, and hydrocephalus. Botelho et al. 40 describe an improvement in respiratory abnormalities in patients with CM-1 after surgery. Based on these results, we propose that the presence of SRBDs be an indication for surgery in oligosymptomatic patients with CM-1. 12 In selecting the most adequate sleep test for SRBD diagnosis in patients with CM-1, the low RDI, absence of related symptoms in most patients, and additional abnormal sleep parameters observed indicate that PSG would be preferable to performing conventional CRP. 84 
Study Limitations
There are a number of limitations in the present study. First, the definitive diagnosis of central or obstructive hypopnea theoretically requires esophageal pressure monitoring, which is rarely done in conventional PSG studies. For this reason, we cannot rule out a central component of hypopnea in some of the respiratory events registered in our patients. However, the presence of flow limitation and snoring during a high proportion of the hypopneas, 85 the higher number of obstructive apneas compared with central apneas, and postural-dependent symptoms suggest that obstructive hypopnea is predominant. Second, because the PSG was performed only during one night, sleep parameter alterations needed to be evaluated carefully because a first-night laboratory effect could not be ruled out. Third, SRBD symptomatic repercussions were only evaluated with ESS scores. More complex procedures evaluating subjective or objective parameters, such as quality-of-life questionnaires or multiple sleep latency tests, were not carried out to evaluate the clinical impact of SRBDs.
CONCLUSIONS
The present study reports on the largest series to date of patients with CM-1 in whom SRBD analysis was systematically conducted. We observed a high incidence of nocturnal respiratory alterations, mainly obstructive hypopneas or apneas and poor sleep efficiency and quality. Based on our findings, we believe that nocturnal PSG should be systematically conducted on all patients diagnosed with CM-1, especially if they present hydrocephalus. Additional risk factors were male sex, older age, and excess weight. Contrary to our initial hypothesis, we cannot confirm that patients with CM-1.5 are more likely to present nocturnal respiratory disorders or other sleep abnormalities. However, further studies evaluating the impact of SRBDs on sleep quality and quality of life in these patients are still needed. In addition, it would be useful to carry out studies to evaluate sleep and respiratory alterations before and after surgery in patients with CM to determine whether surgery treats SRBDs.
